Latest Industry Insights
Industry Insight
Method “Matches” Medicines to Their Unique Protein Receptors
A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.
Industry Insight
A Conversation on the "Latest and Greatest" in Metabolomics
Aided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".
Industry Insight
Life Science Technology Megatrends Shaping Our Future
Megatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.
Industry Insight
Applying Precision Genomics in Biopharma Drug Development
A recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
Industry Insight
One-by-One and All-at-Once: The Future of Cellular Phenotypic Screening
As scientists, we’re often subjected to certain stereotypes. We’re assumed to be smart and nerdy; we work long hours, wear lab coats, and obsess over data. Some or all of these traits and behaviors may ring true at a population level, but for individual scientists they don’t always stack up. The same disconnect applies to cells. We assume that the average phenotype is representative of all of the members of a population, but too often it is not...
Industry Insight
First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing Field
Technology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.
Industry Insight
Measuring Millions of Protein–Protein Interactions Simultaneously
We recently had the pleasure of speaking with David Younger, PhD., Co-founder and CEO of A-Alpha Bio, to learn more about AlphaSeq – a platform designed to measure millions of protein–protein interactions simultaneously.
Industry Insight
Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery
Predicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach. To learn about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.
Industry Insight
Empowering Cancer Patients After Diagnosis
We recently spoke with Jed Coleman, co-founder of Curve.life, an online service aiming to provide cancer patients with evidence-based information about how they can empower themselves after diagnosis.
Industry Insight
Technology Networks Explores the CRISPR Revolution – Coming Soon
Through a series of exclusive interviews with world-renowned scientists and bioethicists, Technology Networks Explores the CRISPR Revolution will investigate the ground-breaking research taking place in the CRISPR space, CRISPR "controversies" and whether the CRISPR technology looks set to fulfil its promise of revolutionizing science.
Advertisement